A new Targeted Translation Research Accelerator Research Plan will shape $77.5 million in funding from the Medical Research Future Fund. An independent Expert Advisory Panel formed the plan. Members tell us how it will improve care and outcomes for people with diabetes and cardiovascular disease.
